Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 1
2(100.0%)
2Total
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05590715Recruiting

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Role: lead

NCT06273540Phase 1Completed

Phase1, STP7 Cocaine Drug-Drug Interaction Study

Role: lead

NCT04644003Phase 1Completed

Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)

Role: lead

NCT04273087Completed

Characterization of a Clinical Subpopulation With Autism Spectrum Disorder

Role: lead

NCT04600882Withdrawn

Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder

Role: lead

All 5 trials loaded